CLINICAL TRIAL: PHASE I TRIAL OF ABRAXANE IN COMBINATION WITH GEMCITABINE IN SOL

该子项目是利用 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 本研究的目的是观察与吉西他滨联合使用时Abraxane的最高剂量。 将测试不同剂量的Abraxane。 给予的吉西他滨量将是标准剂量-未测试不同剂量的吉西他滨。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to see the highest amount of Abraxane that can be given with gemcitabine. Different doses of Abraxane will be tested. The amount of gemcitabine that is given will be the standard dose - different doses of gemcitabine are not being tested.